HIV molecular immunology database
ATGDIIGDIRKAYCNING
|
gp160(318-335) | human epitope |
IRQAHCNISGEKWNN
|
gp160(326-340) | mouse epitope |
SRAKWNNTL
|
gp160(334-342) | B27 human epitope |
SGEDWNKTLSHVVDKLRE
|
gp160(334-351) | human epitope |
SGEDWNKTLSyVVDKLRE
|
gp160(334-351) | inferred escape |
SGEDWNKTLSHVVnKLRE
|
gp160(334-351) | inferred escape |
SGEDWNKTLSHVVDKLRE
|
gp160(334-351) | human epitope |
SGEDWNKTLSyVVDKLRE
|
gp160(334-351) | observed variant |
SGEDWNKTLSHVVnKLRE
|
gp160(334-351) | observed variant |
SGEDWNKTLnHVVDKLRE
|
gp160(334-351) | observed variant |
SGEDWNKTLSHVVaKLRE
|
gp160(334-351) | observed variant |
SGEDWNKTLgHVVDKLRE
|
gp160(334-351) | observed variant |
KWNNTLKQIDSKLREQFGNNKTIIF
|
gp160(337-361) | human epitope |
NNTLKQIDSKLREQFG
|
gp160(339-354) | human epitope |
NNTLKHIVEKLRKQYGS
|
gp160(339-355) | human epitope |
RVLKQVTEK
|
gp160(340-348) | A*11 human epitope |
RVLKQVTEK
|
gp160(340-348) | A11 human epitope |
NTLKQIVIKL
|
gp160(340-349) | Patr-B*14 chimpanzee epitope |
TLSQIVTKL
|
gp160(341-349) | A*02 human epitope |
TLnQIVTKL
|
gp160(341-349) | observed variant |
TLSkIVTKL
|
gp160(341-349) | escape documented in this paper; replicative capacity/ fitness enhanced; observed variant |
TLckIVTKL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkIsTKL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkIaTKL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkIVaKL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkIaTKs
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkmaTrL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSkIVTrL
|
gp160(341-349) | escape documented in this paper; observed variant |
TLSQIaTKL
|
gp160(341-349) | observed variant |
TLSQIVTeL
|
gp160(341-349) | observed variant |
TLSQIVTKL
|
gp160(341-349) | A*02:01 human epitope |
TLSkIVTKL
|
gp160(341-349) | escape documented in this paper |
TLSQIVTKL
|
gp160(341-349) | A*02:01 human epitope |
TLSkIVTKL
|
gp160(341-349) | escape documented in this paper |
TLSQIVTKL
|
gp160(341-349) | A*02:01 human epitope |
TLEQVVKKL
|
gp160(341-349) | human epitope |
ALEQVVKKL
|
gp160(341-349) | observed variant |
MLEQVVKKL
|
gp160(341-349) | observed variant |
TLAQVVKKL
|
gp160(341-349) | observed variant |
TLEQVVEKL
|
gp160(341-349) | susceptible form |
ILEQVVKKL
|
gp160(341-349) | observed variant |
TLEQVVNKL
|
gp160(341-349) | observed variant |
TLDKVVKKL
|
gp160(341-349) | susceptible form |
TLGRVAKKL
|
gp160(341-349) | observed variant |
TLGQVVEKL
|
gp160(341-349) | susceptible form |
TLDKVVEKL
|
gp160(341-349) | susceptible form |
TLGKVVKKL
|
gp160(341-349) | observed variant |
LKQIVTKLQAQFENK
|
gp160(342-356) | mouse epitope |
RVSKKLAEHFPNKTIKF
|
gp160(344-361) | C*04 human epitope |
QIVEKLREIKQFKNKTIVF
|
gp160(344-361) | human epitope |
QIaEKLREIKQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVEKLREIeQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVkKLREIKQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVgKLREIKQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVgKLREIeQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVEKLREIeQFKNKTIaF
|
gp160(344-361) | observed variant |
QIVEKLREIeQFKNrTIVF
|
gp160(344-361) | observed variant |
QIVkKLREIeQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVEKLREIqQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVkKLREmeQFKNKTIVF
|
gp160(344-361) | observed variant |
QIVEKLREIekFKNKTIVF
|
gp160(344-361) | observed variant |
QIVEKLREIKQFKNKkIVF
|
gp160(344-361) | observed variant |
VTKLQAQFENKTIVF
|
gp160(346-361) | mouse epitope |
LQAQFENKTIVFKQS
|
gp160(349-364) | mouse epitope |